N. Klein

发表

Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial

S. Watters, M. Cotton, D. Gibb, 2021, AIDS Research and Therapy.

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

N. Klein, F. Fitzgerald, A. Sarah Walker, 2019 .

Whole genome sequencing of a sporadic primary immunodeficiency cohort

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2018, Nature.

Improving birth weight measurement and recording practices in Kenya and Tanzania: a prospective intervention study with historical controls

S. Kariuki, K. Manji, P. Ashorn, 2021, Population Health Metrics.

The importance of taking ART appropriately in children and adolescents with HIV-1 to reach the highest capacity of immune function later in life

D. Gibbons, A. De Rossi, A. Gkazi, 2022, Frontiers in Immunology.

Profiling gut microbiota and bile acid metabolism in critically ill children

John A. Clark, M. D. de Goffau, J. Parkhill, 2021, Scientific Reports.

Targeted Gene Delivery to Human Airway Epithelial Cells with Synthetic Vectors Incorporating Novel Targeting Peptides Selected by Phage Display

S. E. Barker, H. Hailes, S. Hart, 2004, Journal of drug targeting.

Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1

C. Giaquinto, P. Palma, E. Nastouli, 2021, Journal of the International AIDS Society.

Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2020, The Journal of allergy and clinical immunology.

Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy

I. Pavord, S. Sisodiya, D. Hunt, 2011, European Journal of Human Genetics.

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

Crina Samarghitean, Vera Matser, Scott Hackett, 2018, The Journal of allergy and clinical immunology.

Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence

V. Calvez, C. Giaquinto, P. Palma, 2022, BMC Public Health.

Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)

T. Ndung’u, A. Sigal, P. Goulder, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV

D. Shingadia, E. Chiappini, E. Nastouli, 2016, HIV medicine.

Whole-genome sequencing of a sporadic primary immunodeficiency cohort

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2020, Nature.

T. Ndung’u, A. Sigal, P. Goulder, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Epstein-Barr Virus Reactivation After Paediatric Haematopoietic Stem Cell Transplantation: Risk Factors and Sensitivity Analysis of Mathematical Model

P. Veys, A. Worth, J. Breuer, 2022, Frontiers in Immunology.

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.

C. Giaquinto, T. Puthanakit, Shabinah S. Ali, 2021, The New England journal of medicine.

Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

A. Trkola, P. Tovey, C. Königs, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Response to planned treatment interruptions in HIV infection varies across childhood

J. Ananworanich, J. Darbyshire, F. Monpoux, 2010, AIDS.

CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

C. Königs, C. Giaquinto, D. Gibb, 2019, HIV medicine.

Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy

H. Steen, C. Giaquinto, P. Palma, 2022, Frontiers in Immunology.

Determinants of precocious B-cell aging in European adolescents living with perinatally acquired HIV-1 after over 10 years of suppressive therapy

H. Steen, C. Giaquinto, P. Palma, 2021, bioRxiv.

Arterial Stiffness in a Cohort of Young People Living With Perinatal HIV and HIV Negative Young People in England

H. Kessler, A. Judd, N. Goswami, 2022, Frontiers in Cardiovascular Medicine.

Circulating microparticles are increased amongst people presenting with HIV and advanced immune suppression in Malawi and correlate closely with arterial stiffness: a nested case control study

S. Khoo, R. Heyderman, A. Rapala, 2020, Wellcome open research.

Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV‐1 infection 2015: optimizing health in preparation for adult life

C. Giaquinto, N. Klein, D. Gibb, 2015, HIV medicine.

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

F. Fitzgerald, A. Sarah Walker, V. Mulenga, 2018, The Journal of infectious diseases.

Peter Paul Rickham Prize--1998. Neutrophil dysfunction the cellular mechanism of impaired immunity during total parenteral nutrition in infancy.

N. Klein, A. Pierro, N. Klein, 1999, Journal of pediatric surgery.

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

V. Calvez, D. Pillay, C. Giaquinto, 2015, Journal of virus eradication.

Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors

N. Klein, B. Fehse, R. Thiébaut, 2010, Bone Marrow Transplantation.

‘If I am on ART, my new-born baby should be put on treatment immediately’: Exploring the acceptability, and appropriateness of Cepheid Xpert HIV-1 Qual assay for early infant diagnosis of HIV in Malawi

M. Hosseinipour, D. Fairley, A. Obasi, 2023, PLOS global public health.